109 results
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
, a communication plan to health care practitioners, patient education, extensive patient monitoring or distribution systems and processes that are highly … Schedule (“FSS”), pricing program, established by Section 603 of the Veterans Health Care Act of 1992 (“VHCA”). Under this program, the manufacturer
DEFA14A
BXRXQ
Baudax Bio, Inc.
21 Aug 23
Additional proxy soliciting materials
8:05am
in their respective roles with the Company, are and have been in compliance in all material respects with applicable federal, state, local and foreign health care regulatory … information (collectively, “Health Care Laws”). The Company and its subsidiaries have not received written notice of any claim, action, suit, proceeding
8-K
EX-10.1
BXRXQ
Baudax Bio, Inc.
21 Aug 23
Entry into a Material Definitive Agreement
8:00am
and foreign health care regulatory laws, including without limitation, laws related to fraud and abuse, payment transparency, and privacy and security … of protected health information (collectively, “Health Care Laws”). The Company and its subsidiaries have not received written notice of any claim
424B5
BXRXQ
Baudax Bio, Inc.
18 Aug 23
Prospectus supplement for primary offering
4:40pm
market ANJESO to health care professionals at our called-on institutions for the commercialization of ANJESO in the United States. We continue
DEFA14A
EX-99.1
6p4colhmzuq6 kp6ppt
9 Aug 23
Additional proxy soliciting materials
5:28pm
DEFA14A
EX-99.2
gnr84rq8pbt7hzc0zyu
9 Aug 23
Additional proxy soliciting materials
5:28pm
8-K/A
EX-99.2
ysy4q gsf
9 Aug 23
Other Events
5:27pm
8-K/A
EX-99.1
n1zn rf9z16h1k8wqsef
9 Aug 23
Other Events
5:27pm
DEFA14A
rk1 2c33was
5 Jul 23
Additional proxy soliciting materials
5:28pm
8-K
EX-2.1
2x29kwwzjpal
5 Jul 23
Entry into a Material Definitive Agreement
5:26pm
424B3
8kaoai93zz38
5 Dec 22
Prospectus supplement
4:37pm